Immunome (IMNM) Shares Outstanding (2023 - 2025)
Historic Shares Outstanding for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $91.7 million.
- Immunome's Shares Outstanding rose 5177.73% to $91.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.7 million, marking a year-over-year increase of 5177.73%. This contributed to the annual value of $64.5 million for FY2024, which is 4903.63% up from last year.
- According to the latest figures from Q3 2025, Immunome's Shares Outstanding is $91.7 million, which was up 5177.73% from $87.0 million recorded in Q2 2025.
- In the past 5 years, Immunome's Shares Outstanding ranged from a high of $91.7 million in Q3 2025 and a low of $12.2 million during Q1 2023
- Its 3-year average for Shares Outstanding is $53.6 million, with a median of $60.0 million in 2024.
- Per our database at Business Quant, Immunome's Shares Outstanding soared by 39516.07% in 2024 and then skyrocketed by 4498.84% in 2025.
- Quarter analysis of 3 years shows Immunome's Shares Outstanding stood at $43.3 million in 2023, then surged by 49.04% to $64.5 million in 2024, then soared by 42.27% to $91.7 million in 2025.
- Its last three reported values are $91.7 million in Q3 2025, $87.0 million for Q2 2025, and $87.0 million during Q1 2025.